Creatine phosphokinase elevation exacerbated by levetiracetam therapy

A 19-year-old muscular male with a history of epilepsy presented following two convulsive events. Levetiracetam (LEV) was given as an additional therapy, resulting in a marked boost in creatine phosphokinase (CPK) that could not easily be explained by renal dysfunction or rhabdomyolysis alone. Levet...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacson, Julia E., Choe, Dongwhoon J., Doherty, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308055/
https://www.ncbi.nlm.nih.gov/pubmed/25667904
http://dx.doi.org/10.1016/j.ebcr.2014.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308055/
https://www.ncbi.nlm.nih.gov/pubmed/25667904
http://dx.doi.org/10.1016/j.ebcr.2014.09.008

Ejemplares similares